Dr. David Kosoff

Glenn Liu, MD, is a UW Health medical oncologist and a professor in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health.Dr. Liu specializes in treating advanced genitourinary cancers. These include cancers affecting the urinary and male reproductive organs such as the prostate, bladder, kidneys and testicles. Dr. Liu cares for patients who are both newly diagnosed and those with recurrent (returning) cancer.Dr. Liu’s care philosophy is based on shared decision-making. He believes that listening to patients is essential. He listens to their concerns and educates them about their condition and treatment options. He is excited about the many new discoveries happening now in the field of medical oncology and offers personalized care to best meet his patients’ needs.In addition to his clinical and teaching roles, Dr. Liu researches new cancer therapies. This includes testing new treatments, improving decision-making processes and enhancing how health care teams interact with patients.Outside of work, Dr. Liu enjoys playing tennis, hiking and fishing.Being able to answer questions and provide support and help is very rewarding. Dr. Liu is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and Orchiectomy. Dr. Liu is board certified in Medical Oncology.

Dustin Deming, MD, is a UW Health medical oncologist with a clinical emphasis on gastrointestinal cancers, including colon, rectal, anal, esophageal, liver and pancreatic cancers. He is also a professor at the University of Wisconsin School of Medicine and Public Health in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care. Dr. Deming is known for his commitment to delivering evidence‑based, compassionate care to patients facing complex cancer diagnoses.Dr. Deming’s research program focuses on developing improved treatments for specific subtypes of colon cancer and other gastrointestinal malignancies. His work centers on understanding how tumor‑specific genetic mutations influence treatment response, with the goal of creating personalized therapy regimens for individual patients. By using advanced animal models, his research helps bridge the gap between laboratory discoveries and clinical application.In addition to his translational research, Dr. Deming’s laboratory has developed innovative three‑dimensional cell culture techniques to advance clinical cancer research. He also leads efforts to identify new and improved biomarkers to better predict disease behavior and treatment outcomes. Through his combined roles as a clinician, researcher, and educator, Dr. Deming contributes to advancing precision oncology and improving care for patients with gastrointestinal cancers. Dr. Deming is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, PIK3CA-Related Overgrowth Spectrum, Familial Colorectal Cancer, Anal Cancer, and Liver Embolization. Dr. Deming is board certified in Internal Medicine and Medical Oncology.

Dr. Lang is a professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, Madison, WI. He specializes in genitourinary cancer and medical oncology. Dr. Lang is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Lang is board certified in Internal Medicine and Medical Oncology.